Teva Pharmaceutical Industries Limited (TEVA) : Company Profile and SWOT Analysis

Synopsis

World Market Intelligence's 'Teva Pharmaceutical Industries Limited (TEVA) : Company Profile and SWOT Analysis' contains in depth information and data about the company and its operations. The profile contains a company overview, business description, financial ratios, SWOT analysis, competitive benchmarking, key facts, key employees, location and subsidiaries as well as information on products and services.

Summary

This SWOT analysis and company profile is a crucial resource for industry executives and anyone looking to gain a better understanding of the company's business.

WMI's 'Teva Pharmaceutical Industries Limited (TEVA) : Company Profile and SWOT Analysis' report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format.

WMI strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

Scope

• Examines and identifies key information and issues about 'Teva Pharmaceutical Industries Limited' for business intelligence requirements
• Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported
• Provides analysis on financial ratios along with a competitor benchmarking section
• The profile also contains information on business operations, company history, major products and services, key employees

Reasons To Buy

• Quickly enhance your understanding of the company
• Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry
• Recognize potential partnerships and suppliers
• Obtain yearly profitability figures

Key Highlights

Teva Pharmaceutical Industries Limited (Teva) develops, produces and markets a range of generic and branded pharmaceuticals, biogenerics and active pharmaceutical ingredients (APIs). The company's products focus on various therapeutic areas including multiple sclerosis, Parkinson's disease, autoimmune diseases, oncology, women's health and respiratory disorders. Teva's principal pipeline products include Copaxone for Multiple Sclerosis and Azilect for Parkinson's disease. It operates in 60 countries across the world including Israel, Europe, Asia, North America and Latin America. The company has 56 finished dosage pharmaceutical manufacturing sites, 21 API manufacturing sites and 17 pharmaceutical research and development (R&D) centers. Teva is headquartered in Tikva, Israel.